VolitionRx Limited (VNRX)
AMEX AMEX Primary 
VolitionRx Limited (VNRX) Q3 2025 Earnings Call Transcript
VolitionRx Limited ( VNRX ) Q3 2025 Earnings Call November 14, 2025 8:30 AM EST Company Participants Louise Batchelor Day - Group Chief Marketing & Communications Officer Cameron Reynolds - Founder, CEO, President & Director Jacob Micallef - Chief Scientific Officer Terig Hughes - CFO & Treasurer Conference Call Participants Justin Walsh - JonesTrading Institutional Services, LLC, Research Division Yi Chen - H.C. Wainwright & Co, LLC, Research Division Steven Ralston - Zacks Investment Research, Inc. Bruce Jackson - The Benchmark Company, LLC, Research Division Presentation Operator Good morning, ladies and gentlemen, and thank you for standing by.
VolitionRx Limited - Special Call
VolitionRx Limited - Special Call Company Participants Marielle Herzog Conference Call Participants Alexandra Byrne Eric Ariazi Presentation Alexandra Byrne Great. Good morning, everyone.
VolitionRx Limited (VNRX) Q2 2025 Earnings Call Transcript
VolitionRx Limited (NYSE:VNRX ) Q2 2025 Earnings Conference Call August 15, 2025 8:30 AM ET Company Participants Andrew Retter - Chief Medical Officer Cameron Reynolds - Founder, CEO, President & Director Louise Batchelor Day - Group Chief Marketing & Communications Officer Terig Hughes - CFO & Treasurer Conference Call Participants Bruce David Jackson - The Benchmark Company, LLC, Research Division Jason Howard Kolbert - D. Boral Capital LLC, Research Division Justin Howard Walsh - JonesTrading Institutional Services, LLC, Research Division Yi Chen - H.C.
VolitionRX Limited (VNRX) Q1 2025 Earnings Call Transcript
VolitionRX Limited (NYSE:VNRX ) Q1 2025 Earnings Conference Call May 16, 2025 8:30 AM ET Company Participants Louise Batchelor – Chief Marketing and Communications Officer Terig Hughes – Chief Financial Officer Cameron Reynolds – Chief Executive Officer Conference Call Participants Steven Ralston – Zacks Ilya Zubkov – Freedom Broker Operator Good morning, ladies and gentlemen. Thank you for standing by.
VolitionRx Limited (VNRX) Q4 2024 Earnings Call Transcript
VolitionRx Limited (NYSE:VNRX ) Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ET Company Participants Louise Batchelor - Chief Marketing & Communications Officer Cameron Reynolds - President & Chief Executive Officer Terig Hughes - Chief Financial Officer Andrew Retter - Chief Medical Officer Conference Call Participants Bruce Jackson - The Benchmark Company Ilya Zubkov - Freedom Broker Steven Ralston - Zacks Investment Research Operator Good afternoon ladies and gentlemen and thank you for standing by. Welcome to VolitionRx Limited Fourth Quarter and Full Fiscal Year 2024 Earnings Conference Call.
VolitionRx Limited (VNRX) Q3 2024 Earnings Call Transcript
VolitionRx Limited (NYSE:VNRX ) Q3 2024 Earnings Conference Call November 15, 2024 8:30 AM ET Company Participants Louise Batchelor - Chief Marketing & Communications Officer Tom Butera - CEO, Volition Veterinary Diagnostic Development Andrew Retter - Chief Medical Officer Terig Hughes - CFO Cameron Reynolds - President & CEO Conference Call Participants Jason Kolbert - D. Boral Capital Ilya Zubkov - Freedom Broker Steven Ralston - Zacks Investment Research Bruce Jackson - The Benchmark Company Operator Good day, ladies and gentlemen.
VolitionRx Limited (VNRX) Q2 2024 Earnings Call Transcript
VolitionRx Limited (NYSE:VNRX ) Q2 2024 Earnings Conference Call August 15, 2024 8:30 AM ET Company Participants Louise Batchelor - Chief Marketing and Communications Officer Cameron Reynolds - President and CEO Terig Hughes - CFO Andrew Retter - CMO Gael Forterre - CCO Conference Call Participants Bruce Jackson - The Benchmark Company Ilya Zubkov - Freedom Broker Steven Ralston - Zacks Small-Cap Research Operator Good morning, ladies and gentlemen, and thank you for standing by. Welcome to the VolitionRx Limited's Second Quarter 2024 Earnings Conference Call.
